Gene · 6195
Papers3,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-GBM effects of polyphenolic extract from Avicennia marina. | J Ethnopharmacol | 2025 | 40490234 | PubTator, text mining | PubMed |
| Association of placental weight and placental-fetal weight ratio with DNA methylation in placenta. | Epigenomics | 2025 | 40415454 | PubTator, text mining | PubMed |
| Luteolin targets MKK4 to attenuate particulate matter-induced MMP-1 and inflammation in human keratinocytes. | Sci Rep | 2025 | 40374763 | PubTator, text mining | PubMed |
| Identifcation of the FGF family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. | SLAS Technol | 2025 | 40086631 | PubTator, text mining | PubMed |
| Cytosolic CRISPR RNAs for efficient application of RNA-targeting CRISPR-Cas systems. | EMBO Rep | 2025 | 40011676 | PubTator, text mining | PubMed |
| Correction: Overexpressed RPS6KA1 and its potential diagnostic value in head and neck squamous cell carcinoma. | Discov Oncol | 2025 | 39976878 | PubTator, text mining | PubMed |
| Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinib. | Emerg Microbes Infect | 2025 | 39976482 | PubTator, text mining | PubMed |
| Phospho-seq: integrated, multi-modal profiling of intracellular protein dynamics in single cells. | Nat Commun | 2025 | 39905064 | PubTator, text mining | PubMed |
| Overexpressed RPS6KA1 and its potential diagnostic value in head and neck squamous cell carcinoma. | Discov Oncol | 2025 | 39827419 | PubTator, text mining | PubMed |
| RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia. | Nat Commun | 2025 | 39820365 | PubTator, text mining | PubMed |
| PTMNavigator: interactive visualization of differentially regulated post-translational modifications in cellular signaling pathways. | Nat Commun | 2025 | 39779715 | PubTator, text mining | PubMed |
| A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. | Neoplasia | 2025 | 39541736 | PubTator, text mining | PubMed |
| Advances in reversible covalent kinase inhibitors. | Med Res Rev | 2025 | 39287197 | PubTator, text mining | PubMed |
| Translational machinery and translation regulation in axon regeneration. | Neural Regen Res | 2025 | 39075899 | PubTator, text mining | PubMed |
| The potential of some functional group compounds substituted 8-Manzamine A as RSK1 inhibitors: molecular docking and molecular dynamics simulations. | J Biomol Struct Dyn | 2025 | 38319051 | PubTator, text mining | PubMed |
| Discovery of potential RSK1 inhibitors for cancer therapy using virtual screening, molecular docking, molecular dynamics simulation, and MM/GBSA calculations. | J Biomol Struct Dyn | 2025 | 38084766 | PubTator, text mining | PubMed |
| RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data. | Expert Opin Ther Targets | 2024 | 39632509 | PubTator, text mining | PubMed |
| RSK1 dependency in FLT3-ITD acute myeloid leukemia. | Blood Cancer J | 2024 | 39592591 | PubTator, text mining | PubMed |
| The MAPK/ERK signaling pathway involved in Raddeanin A induces apoptosis via the mitochondrial pathway and G2 phase arrest in multiple myeloma. | Sci Rep | 2024 | 39580496 | PubTator, text mining | PubMed |
| Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays. | Elife | 2024 | 39526730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6195/papers?page=4